Filter News
Area of Research
- (-) National Security (25)
- (-) Neutron Science (24)
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (44)
- Building Technologies (1)
- Clean Energy (80)
- Climate and Environmental Systems (1)
- Computational Biology (2)
- Computational Engineering (3)
- Computer Science (15)
- Electricity and Smart Grid (3)
- Functional Materials for Energy (1)
- Fusion and Fission (7)
- Fusion Energy (2)
- Isotopes (6)
- Materials (65)
- Materials for Computing (16)
- Mathematics (1)
- Quantum information Science (8)
- Sensors and Controls (1)
- Supercomputing (128)
News Topics
- (-) Biomedical (15)
- (-) Computer Science (33)
- (-) Frontier (2)
- (-) Grid (6)
- (-) Mathematics (1)
- (-) Microscopy (3)
- (-) Polymers (1)
- 3-D Printing/Advanced Manufacturing (12)
- Advanced Reactors (12)
- Artificial Intelligence (18)
- Big Data (8)
- Bioenergy (10)
- Biology (9)
- Biotechnology (2)
- Buildings (1)
- Chemical Sciences (4)
- Clean Water (2)
- Climate Change (5)
- Composites (1)
- Coronavirus (11)
- Cybersecurity (19)
- Decarbonization (5)
- Energy Storage (8)
- Environment (13)
- Exascale Computing (1)
- Fossil Energy (1)
- Fusion (10)
- High-Performance Computing (6)
- Isotopes (5)
- Machine Learning (15)
- Materials (16)
- Materials Science (27)
- Molten Salt (4)
- Nanotechnology (11)
- National Security (34)
- Neutron Science (101)
- Nuclear Energy (41)
- Partnerships (4)
- Physics (11)
- Quantum Computing (1)
- Quantum Science (8)
- Security (12)
- Simulation (1)
- Space Exploration (8)
- Summit (7)
- Sustainable Energy (5)
- Transformational Challenge Reactor (3)
- Transportation (7)
Media Contacts
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.